Filing Details
- Accession Number:
- 0001225208-13-003756
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-12 16:03:51
- Reporting Period:
- 2013-02-08
- Filing Date:
- 2013-02-12
- Accepted Time:
- 2013-02-12 16:03:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385187 | Covidien Plc | COV | Surgical & Medical Instruments & Apparatus (3841) | 980624794 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1524349 | C Bryan Hanson | C/O Covidien 15 Hampshire Street Mansfield MA 02048 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2013-02-08 | 2,636 | $54.22 | 23,380 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2013-02-08 | 2,636 | $63.15 | 20,744 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2013-02-11 | 500 | $63.06 | 20,244 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-02-08 | 2,636 | $0.00 | 2,636 | $54.22 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,909 | 2021-06-30 | No | 4 | M | Direct |
Footnotes
- The price reported is a weighted average price. Shares were sold in two transactions at prices of $63.1550 and $63.1500. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
- Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.
Billionaire Hedge Funds
